Type: article
Abstract: Background: Chemoresistance represents a major obstacle in cancer therapy, often associated with enhanced drug efflux.This study aimed to generate and characterize cisplatin-resistance in C-33A cells (C-33A RCDDP), and included, for comparison, a previously established paclitaxel-resistant subline (C-33A RPTX) overexpressing transporters, such as ABCB1, ABCG4, and ABCC8.In addition, we assessed whether the morpholine KECH-18D could restore drug sensitivity by enhancing intracellular drug accumulation.Materials and Methods: C-33A RCDDP cells were developed by stepwise cisplatin (CDDP) exposure.Cytotoxicity assays of nine morpholines were carried out to identify structural determinants of anticancer activity in the C-33A cell line.Combinatorial assays with morpholine KECH-18D and CDDP or paclitaxel (PTX) were performed to determine whether KECH-18D chemosensitizes and retains the drug in C-33A RCDDP and C-33A RPTX cells.Results: C-33A RCDDP cells exhibited a 4.7-fold increase in CDDP resistance.C-33A RCDDP and C-33A RPTX cells both displayed cross-resistance patterns, but C-33A RTPX cells retained lower levels of the drug than C-33A RCDDP cells.Furthermore, KECH-18D maintained strong cytotoxicity against chemoresistant cell lines and enhanced the cytotoxicity of CDDP and PTX against them.Notably, KECH-18D increased drug accumulation in C-33A RCDDP cells in a time-dependent manner, but not in C-33A RPTX cells.Conclusion: In summary, C-33A RCDDP and C-33A RPTX cells developed different levels, and possibly mechanisms, of resistance.Because the morpholine KECH-18D resulted highly cytotoxic in both parental and chemoresistant cells, enhanced drug retention in C-33A RCDDP cells and increased the toxicity of CDDP or PTX in chemoresistant cells, KECH-18D is a promising scaffold for overcoming multidrug resistance by selectively modulating drug efflux-related and -unrelated phenotypes, though further studies are necessary to deep its mechanisms of action.
Source: RWTH Publications (RWTH Aachen)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Universidad Autónoma de Sinaloa
OpenAlex ID: W7017430212
